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BACKGROUND: Fat intake has been postulated to increase risk of ovarian cancer, but previous studies have reported inconsistent
results.
METHODS: The NIH-AARP Diet and Health Study, a large prospective cohort, assessed diet using a food frequency questionnaire
at baseline in 1995–1996. During an average of 9 years of follow-up, 695 ovarian cancer cases were ascertained through the state
cancer registry database. The relative risks (RRs) and 95% confidence interval (CI) were estimated using a Cox proportional hazard
model.
RESULTS: Women in the highest vs the lowest quintile of total fat intake had a 28% increased risk of ovarian cancer (RRQ5 vs Q1¼1.28,
95% CI: 1.01–1.63). Fat intake from animal sources (RRQ5 vs Q1¼1.30; 95% CI: 1.02–1.66), but not from plant sources, was
positively associated with ovarian cancer risk. Saturated and monounsaturated fat intakes were not related to risk of ovarian cancer,
but polyunsaturated fat intake showed a weak positive association. The association between total fat intake and ovarian cancer was
stronger in women who were nulliparous or never used oral contraceptives.
CONCLUSION: Fat intake, especially from animal sources, was related to an increased risk of ovarian cancer. The association may be
modified by parity and oral contraceptive use, which warrants further investigation.
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Ovarian cancer, which is often diagnosed at an advanced stage, is
the eighth most common cancer and the fifth leading cause of
cancer death in women in the United States (Kohler et al, 2011).
Although the causes of ovarian cancer have been hypothesised as
environmental factors, few modifiable risk factors have been
identified. Among known risk factors, oral contraceptive use is
associated with a lower risk of ovarian cancer, while menopausal
hormone therapy (MHT) use corresponds to an increased risk
(Schottenfeld and Fraumeni, 2006). Both oral contraceptive and
MHT uses are speculated to have a role in ovarian cancer aetiology
partially by affecting hormones such as gonadotropins, androgens,
progesterone, and oestrogens, which may promote ovarian
carcinogenesis (Lukanova and Kaaks, 2005). Another factor that
is postulated to increase risk of ovarian cancer by altering
hormone levels, particularly oestrogen levels, is high-dietary fat
intake (Cramer and Welch, 1983; Wu et al, 1999). Nevertheless,
observational studies have reported inconsistent results and a
recent expert panel report could not make a judgment on the
association between fat intake and risk of ovarian cancer due to
limited evidence (World Cancer Research Fund AIfCR, 2007). An
early meta-analysis of seven case–control studies and one
prospective cohort study (Huncharek and Kupelnick, 2001)
summarised that total fat intake was significantly related to risk
of ovarian cancer (relative risk (RR)¼1.24, 95% confidence
interval (CI): 1.07–1.43 comparing the highest vs the lowest
category). However, a recent pooled analysis of 12 cohort studies
(Genkinger et al, 2006) found no association between total fat
intake and ovarian cancer risk, but weak positive associations with
saturated fat intake and fat intake from animal foods. Comparing
the highest with the lowest quartile of intake, the RR was 1.14 (95%
CI: 0.97–1.34) for saturated fat intake and 1.15 (95% CI: 0.99–
1.33) for fat intake from animal foods. Given that the range of fat
intake across studies was relatively narrow, the pooled analysis
may have limited power to detect an association, if it exists.
Therefore, we examined the association between fat intake and risk
of ovarian cancer in a large prospective cohort study that included
695 ovarian cancer cases and had a wide range of fat intake. We
further investigated sources and types of fat and histological
subtypes of ovarian cancer. In addition, we tested whether the
association between fat intake and ovarian cancer differed by oral
contraceptive use, parity, MHT use, and body mass index (BMI).
MATERIALS AND METHODS
Study population
The NIH-AARP Diet and Health Study was initiated in 1995–1996
when a self-administered questionnaire was sent out only once to
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y3.5 million men and women, aged 50–71 years, who were members
of the AARP (formerly known as the American Association of
Retired Persons) and resided in one of six states (California,
Florida, Louisiana, New Jersey, North Carolina, and Pennsylvania)
or two metropolitan areas (Atlanta, Georgia or Detroit, Michigan).
The response to the one-time mailing was 17.6%. Details of the
study have been described previously (Schatzkin et al, 2001).
Of the 567169 participants who returned the baseline ques-
tionnaire, we excluded individuals who returned duplicate
questionnaires (n¼179), requested to be withdrawn (n¼7), had
moved out of the study area or died before baseline (n¼582),
responded as proxies for the intended respondents (n¼15760),
were male (n¼325174), had any prevalent cancer other than non-
melanoma skin cancer at baseline (n¼23953), had end-stage renal
disease (n¼371), or had undergone bilateral oophorectomy
(n¼48145). In addition, we excluded individuals who reported
extreme intakes (greater than twice the interquartile ranges above
the 75th percentile or below the 25th percentile of sex-specific log-
transformed intake) of total energy (n¼1300) and total fat
(n¼146). After these exclusions, the analytical cohort consisted
of 151552 women. The study was approved by the Special Studies
Institutional Review Board of the National Cancer Institute (NCI).
Diet and risk-factor assessment
We assessed dietary intake with a 124-item food frequency
questionnaire that was based on the earlier version of the NCI
Diet History Questionnaire. We assessed frequency of food and
beverage consumption for the previous 12 months using 10 pre-
defined categories of intake ranging from ‘never’ to ‘6þ times per
day’ for beverages, and ‘never’ to ‘2þ times per day’ for solid
foods. Portion sizes and nutrient intakes were estimated from the
1994–1996 US Department of Agriculture’s Continuing Survey of
Food Intakes by Individuals. The food frequency questionnaire
included 21 questions about consumption of foods that were low
fat and those that contained added fats or creamers used in food
preparation. In addition to total fat, we also estimated fat intake by
sources of fat, including fat from animal sources (e.g., meat, egg,
dairy, butter, etc.) and fat from plant sources (e.g., vegetable oil,
margarine, etc.), and by types of fat, including saturated,
monounsaturated, polyunsaturated and trans fat.
The food frequency questionnaire was validated in a calibration
study (n¼1953) using two nonconsecutive 24-h dietary recalls as a
reference method (Thompson et al, 2008). The energy-adjusted
Pearson correlation coefficients for the food frequency question-
naire and the 24-h dietary recalls in women were 0.62 for total fat,
0.69 for saturated fat, 0.62 for monounsaturated fat, and 0.56 for
polyunsaturated fat.
The baseline questionnaire also collected information about
non-diet risk factors, including demographic characteristics
(e.g., race/ethnicity and level of education), height, body weight,
medical history (e.g., heart disease, stroke, diabetes), family
history of cancer, smoking status, time since quitted smoking,
number of cigarettes per day, oral contraceptive use, MHT use, and
reproductive history (e.g., parity, age at first birth, age at
menarche, age at menopause). A subsequent questionnaire was
mailed to people who did not have self-reported prevalent cancer
at baseline within 6 months from the time the baseline
questionnaire (response rate¼62%). It asked for more detailed
family history of cancer including ovarian cancer and medical
history (e.g., hypertension, medication use).
Cohort follow-up
Study participants were followed by annual matching of the cohort
database with the National Change of Address database
maintained by the US Postal Service and through processing of
undeliverable mail, other address update services and direct
responses from participants. Vital status was ascertained by
linkage to the US Social Security Administration Death Master
File with verification in the National Death Index Plus. The loss-to-
follow-up is less than 5%.
Cancer ascertainment
We identified cancer cases through linkage of the study
participants to eight original and two additional (Arizona and
Texas) state cancer registry databases. Cancer registries have been
certified by the North American Association of Central Cancer
Registries to capture at least 90% of cancer incidences within
2 years of cancer occurrence. Our case ascertainment method has
been described previously, which demonstrated that approxi-
mately 90% of cancers were identified through cancer registries
(Michaud et al, 2005). Cancer registry data included cancer
diagnosed, diagnosis date, morphology code, grade, and stage
information.
We defined cases as invasive, first primary epithelial ovarian
cancer using the International Classification of Diseases
for Oncology, Third Edition [16], code C56.9. Borderline and
non-epithelial ovarian cancer cases were not included as cases in
this study. We further classified the epithelial ovarian cancer into
the following subtypes: serous (morphology code: 8260, 8441,
8450, 8460, 8461, 8462), endometrioid (morphology code: 8380,
8381, 8560, 8570), mucinous (morphology code: 8470, 8471, 8472,
8480, 8481, 8490), clear cell (morphology code: 8310, 8313), and
other tumours.
Statistical analysis
We estimated RRs and 95% CIs with Cox proportional hazards
models (Cox, 1972) using the PHREG procedure in SAS (SAS,
Institute , Cary, NC, USA). All reported P-values were two-sided. We
calculated person-years of follow-up time from the date when the
questionnaire was returned until participants were diagnosed with
cancer, moved out of the cancer registry ascertainment area, died, or
the end of follow-up was reached (31 December 2006), whichever
occurred first. We confirmed the proportional hazards assumption
was met for the main exposure and other covariates by including
interaction terms with time and using the Wald w
2-procedure to test
whether all coefficients equaled 0 (Ng’andu, 1997).
To adjust total energy intake in models, we used a nutrient
density method, in which fat intake was expressed as a percentage
of total energy intake. In analysis of sources and types of fat,
we mutually adjusted for all other sources and types of fat. For
example, the RR for saturated fat intake represents the association
of ovarian cancer risk with the substitution of non-fat energy
sources and is independent of monounsaturated and polyunsatu-
rated fat intake (Willett, 1998).
We performed analyses using fat as either a categorical or
continuous variable. We created quintiles and deciles of fat intake,
based on the distribution in the study population. In categorical
analyses, we also tested whether there was a linear trend across the
categories using the median value of each category as a single
continuous variable in a model. Before conducting analyses of
fat intakes as continuous variables, we evaluated the relation of fat
intake to ovarian cancer using a nonparametric regression curve
that used a restricted cubic spline. We found the associations
between total fat and all types of fat and ovarian cancer, including
subtypes, were linear. Relative risks in continuous analyses were
estimated for a 10% increase in total fat intake as percentage of
total energy intake, and for a 5% increase in sources and types of
fat intake as a percentage of total energy intake.
In multivariate models, we adjusted for age, race (white,
non-Hispanic, black, non-Hispanic, others), education (o12 years,
high-school graduate, some college, and college graduate/
post college), BMI (o25, 25–30, 30þ kgm
 2), family history of
Fat intake and ovarian cancer
MM Blank et al
597
British Journal of Cancer (2012) 106(3), 596–602 & 2012 Cancer Research UK
E
p
i
d
e
m
i
o
l
o
g
yovarian cancer (yes, no), duration of oral contraceptive use
(0, 1–4, 5–9, 10þ years), parity (0, 1, 2, 3–4, and 5þ children),
duration of MHT use (0, 40–o5, 5–9, 10þ years), and total
energy intake. We created an indicator variable for missing
responses in each covariate. The proportion of missing for each
variable was generally o4%. In additional analyses, we further
adjusted for physical activity and smoking and found that the
results did not change. We also performed sensitivity analyses by
excluding cases diagnosed within the first 2 years of follow-up and
found similar results. To examine whether the associations for fat
intake differed by oral contraceptive use, parity, MHT use, and
BMI, we included cross product terms of the ordinal score of the
level of each factor and fat intake expressed as a continuous
variable in the multivariate models.
We conducted measurement error corrections for the associa-
tion between total fat intake and risk of ovarian cancer using the
calibration substudy data. Using a regression calibration method
for the case of multiple covariates measured with error (Rosner
et al, 1990; Spiegelman et al, 2001) and a SAS macro (Logan and
Spiegelman, 2004), we simultaneously corrected for measurement
error in fat and total energy intakes and adjusted for age,
race, education, BMI, family history of ovarian cancer, oral
contraceptive use, parity, and MHT use.
RESULTS
During an average of 9 years of follow-up, a total of 695 ovarian
cancer cases were identified. Overall, 404 ovarian cancer cases were
classified as serous tumour, 66 were endometroid, 36 were
mucinous, 24 were clear cell tumours, and 165 were other
epithelial tumour types or were not otherwise specified. Total fat
intake ranged from 20% of total energy intake (10th percentile) to
40% of total energy intake (90th percentile). Median intake
of fat from animal and vegetable sources was 14.1% and 11.7% of
total energy intake, respectively. The major type of fat was
monounsaturated fat (10th–90th percentile: 7–15%) followed by
saturated fat (10th–90th percentile: 6–13%), and polyunsaturated
fat (10th–90th percentile: 4–10%). These types of fat were
correlated with each other (Pearson correlation coefficient between
saturated fat and monounsaturated fat¼0.82; between saturated
and polyunsaturated¼0.45; between monounsaturated and poly-
unsaturated¼0.75). Major food sources of saturated fat were dairy
(22%), meat (20%), and butter/margarine (16%). Foods contribut-
ing to monounsaturated fat intake were meat (21%), butter/
margarine (12%), and vegetable oils including salad dressing (9%).
Main sources of polyunsaturated fat intake were vegetable oils
including salad dressing (20%), butter/margarine (13%), mayo-
nnaise (11%), and meat (10%). In general, women in the highest
quintile of total fat intake were more likely to be Caucasian, have a
higher BMI, a lower educational level, higher parity, and have
never used MHT (Table 1). The duration of oral contraceptive use
did not differ by total fat intake.
We found that total fat intake was significantly positively
associated with risk of ovarian cancer. Compared with the lowest
quintile of total fat intake, women in the highest quintile had a
28% increased risk of ovarian cancer (multivariate RRQ5 vs Q1
¼1.28, 95% CI: 1.01–1.63, Ptrend¼0.04; Table 2). When we
examined the association by comparing the highest decile of total
fat intake (median¼43% of total energy from fat) with the lowest
(median¼17% of total energy from fat), we found a multivariate
RR of 1.49 (95% CI: 1.06–2.11, Ptrend¼0.03) for ovarian cancer.
Fat intake from animal sources was significantly positively related
to the risk of ovarian cancer (multivariate RRQ5 vs Q1¼1.30, 95%
CI: 1.02–1.66, Ptrend¼0.03), but fat intake from plant sources
was not (multivariate RRQ5 vs Q1¼1.00, 95% CI: 0.79–1.27,
Ptrend¼0.96). We further examined whether types of fat were
related to ovarian cancer risk. We observed that saturated and
monounsaturated fat intakes were not related to risk of ovarian
cancer, but polyunsaturated fat intake suggested a weak positive
association with risk of ovarian cancer (multivariate RRQ5 vs Q1
¼1.28, 95% CI: 0.92–1.77, Ptrend¼0.09). Intake of trans fat
also showed a statistically nonsignificant positive association with
risk of ovarian cancer (multivariate RRQ5 vs Q1¼1.19, 95% CI:
Table 1 Characteristics of women by quintiles of total fat intake in the NIH-AARP Diet and Health Study
Quintiles of total fat intake
12345
N 30310 30311 30311 30311 30310
Age at study entry (years)
a 61.8 (5.4) 61.8 (5.4) 61.7 (5.5) 61.7 (5.4) 61.6 (5.4)
Body mass index (kgm
 2)
a 25.4 (5.3) 26.3 (5.6) 26.9 (5.9) 27.3 (6.2) 27.9 (6.9)
Total energy intake (kcal)
a 1465 (620) 1491 (594) 1555 (623) 1632 (663) 1707 (715)
White, non-Hispanic (%) 89 90 90 90 91
College and post-graduate (%) 38 35 32 28 24
Family history of ovarian cancer (%)
b 34444
Oral contraceptives use (%)
c
Never or o1 year 59 59 58 59 59
1–4 Years 18 18 18 18 18
5–9 Years 13 13 13 13 12
10+ Years 9 10 10 10 10
Parity (%)
c
0 1 71 61 51 51 4
1 Child 11 10 10 10 10
2 Children 28 27 26 25 25
3+ Children 45 48 48 50 51
Menopausal hormone therapy use (%)
c
Never 50 50 51 53 56
o10 Years 35 35 33 32 29
10+ Years 13 14 14 14 13
aMean and standard deviation.
bFrom a subcohort.
cDo not add up to 100% due to missing category.
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during the first 2 years of follow-up to exclude cases that
may have changed their diet due to early symptoms of cancer,
we found that the results did not change: the multivariate
RRQ5 vs Q1 were 1.34 (95% CI: 1.03–1.76) for total fat intake;
1.30 (95% CI: 1.00–1.70) for fat from animal food; 1.08 (95% CI:
0.82–1.41) for fat from plant food; 1.00 (95% CI: 0.66–1.52) for
saturated fat intake; 1.01 (95% CI: 0.61–1.69) for monounsaturated
fat; and 1.37 (95% CI: 0.95–1.97) for polyunsaturated fat.
In analyses using total fat intake as a continuous variable
(Table 3), we observed an 11% increased risk of ovarian cancer per
increment of 10% of total energy from fat (multivariate RR¼1.11,
95% CI: 1.01–1.23) and 28% increased risk of ovarian cancer
for polyunsaturated fat intake (multivariate RR¼1.28, 95% CI:
1.02–1.61, per increment of 5% of total energy from polyunsatu-
rated fat intake). When we corrected for measurement errors in the
assessments of total fat intake, we found that the association
between total fat intake and ovarian cancer became robust. After
correction for measurement errors, the multivariate RR for ovarian
cancer was 1.26 (95% CI: 1.02–1.55) for an increment of 10%
of total energy from fat.
We further examined total fat intake in relation to ovarian
cancer subtypes (Table 3). Intake of total fat as well as fat from
animal sources was positively associated with risk of serous
tumour, the most common histological subtype of ovarian
cancer. The multivariate RR of serous tumour was 1.14 (95% CI:
1.00–1.30) for 10% increment of total energy from total fat and
1.10 (95% CI: 1.01–1.20) for 5% increment of total energy from fat
from animal sources. Fat intake was not related to risk of
endometroid tumour, whereas results for mucinous tumour were
similar to those of serous tumour. However, due to low numbers
for endometroid and mucinous tumour, the power to detect an
association may have been insufficient. There were no statistically
significant heterogeneities in associations of fat intake and ovarian
cancer subtypes (P-tests for heterogeneities 40.17).
We found a statistically significant interaction for the associa-
tion between total fat intake and risk of ovarian cancer by parity
(P-value for interaction¼0.01); however, there were no inter-
actions by oral contraceptive use, MHT use, or BMI (Figure 1).
The association between total fat intake and risk of ovarian cancer
was significant in women who were nulliparous (multivariate
RR¼1.37, 95% CI: 1.10–1.71 for increment of 10% of total energy
from fat) and in women who had 1–2 children (multivariate
RR¼1.19, 95% CI: 1.02–1.40), but not in women who had more
than three children (P-value for interaction¼0.01). Although
no significant interaction by oral contraceptive use was observed,
Table 2 Relative risks and 95% confidence intervals of ovarian cancer by quintiles of total fat intake in the NIH-AARP Diet and Health Study
Quintiles of total fat intake
a
1 2345 Ptrend
Total fat
Median intake
b 19.9 25.7 29.8 33.9 39.9
Cases (N)/Person-years 126/285549 126/285533 159/284164 130/281952 154/280665
Age-adjusted 1.00 1.00 (0.78–1.28) 1.27 (1.01–1.61) 1.05 (0.82–1.34) 1.26 (0.99–1.59) 0.06
Multivariate
c 1.00 1.00 (0.79–1.29) 1.29 (1.02–1.63) 1.06 (0.83–1.36) 1.28 (1.01–1.63) 0.04
Fat from animal sources
Median intake
b 7.9 11.3 14.1 17.1 22.0
Cases (N)/Person-years 127/285983 137/285951 136/284164 142/282240 153/279526
Age-adjusted 1.00 1.09 (0.85–1.38) 1.09 (0.86–1.39) 1.16 (0.91–1.47) 1.27 (1.00–1.61) 0.04
Multivariate
c 1.00 1.09 (0.86–1.39) 1.11 (0.87–1.41) 1.18 (0.92–1.50) 1.30 (1.02–1.66) 0.03
Fat from plant sources
Median intake
b 6.4 9.3 11.7 14.5 19.5
Cases (N)/Person-years 133/283730 129/284373 160/284157 138/283276 135/282627
Age-adjusted 1.00 0.97 (0.76–1.24) 1.20 (0.95–1.51) 1.03 (0.81–1.31) 1.01 (0.79–1.28) 0.92
Multivariate
c 1.00 0.96 (0.75–1.22) 1.18 (0.94–1.49) 1.02 (0.80–1.30) 1.00 (0.79–1.27) 0.96
Saturated fat
Median intake
b 5.7 7.5 9.0 10.6 13.2
Cases (N)/Person-years 126/285889 143/285801 144/284051 147/282055 135/280067
Age-adjusted 1.00 1.14 (0.90–1.45) 1.16 (0.91–1.47) 1.20 (0.95–1.53) 1.11 (0.87–1.42) 0.39
Multivariate
c 1.00 1.07 (0.80–1.42) 1.06 (0.77–1.46) 1.10 (0.78–1.55) 1.03 (0.71–1.50) 0.98
Monounsaturated fat
Median intake
b 7.1 9.4 11.1 12.7 15.1
Cases (N)/Person-years 125/285597 132/285025 157/284257 134/282618 147/280366
Age-adjusted 1.00 1.06 (0.83–1.36) 1.27 (1.00–1.60) 1.09 (0.86–1.39) 1.21 (0.95–1.54) 0.13
Multivariate
c 1.00 1.00 (0.73–1.37) 1.14 (0.79–1.64) 0.95 (0.63–1.43) 1.01 (0.63–1.60) 0.87
Polyunsaturated fat
Median intake
b 4.5 5.8 6.8 8.0 10.2
Cases (N)/Person-years 125/283971 125/284901 144/283464 139/283363 162/282165
Age-adjusted 1.00 1.00 (0.78–1.28) 1.15 (0.91–1.47) 1.11 (0.87–1.41) 1.30 (1.03–1.64) 0.02
Multivariate
c 1.00 0.97 (0.74–1.27) 1.11 (0.83–1.47) 1.08 (0.80–1.47) 1.28 (0.92–1.77) 0.09
aQuintiles based on the distribution in the study population. Cutpoints for each quintile are 23.2, 27.8, 31.8, and 36.4 for total fat; 9.8, 12.7, 15.5, and 19.1 for fat from animal
sources; 8.0, 10.4, 13.0, and 16.5 for fat from plant sources; 6.7, 8.3, 9.8, and 11.6 for saturated fat; 8.4, 10.3, 11.9, and 13.7 for monounsaturated fat; 5.2, 6.3, 7.4, and 8.9 for
polyunsaturated fat.
bPercent from total energy intake from fat.
cAdjusted for age, race (white, non-Hispanic, black, non-Hispanic, others), education (o12 years, high-school
graduate, some college, and college graduate/post college), body mass index ( o25, 25–30, 30+ kgm
 2), family history of ovarian cancer (yes, no), duration of oral
contraceptive use (0, 1–4, 5–9, 10+ years), parity (0, 1, 2, 3–4, and 5+ children), duration of menopausal hormone therapy use (0, 40-o5, 5–9, 10+ years), and total energy
intake (continuous).
dMutually adjusted for all other sources and types of fat in analysis of sources and types of fat.
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stronger among women who never took oral contraceptives
(multivariate RR¼1.17, 95% CI: 1.04–1.32 for increment of 10%
of total energy intake) than among women who had ever taken oral
contraceptives (multivariate RR¼0.98, 95% CI: 0.82–1.17).
Menopausal hormone therapy use and BMI did not modify the
association between total fat intake and risk of ovarian cancer.
DISCUSSION
In this large prospective cohort study, we found that intakes of
total fat and fat from animal sources were significantly positively
associated with risk of ovarian cancer. Intakes of saturated and
monounsaturated fat were not related to risk of ovarian cancer,
whereas polyunsaturated fat intake showed a weak positive
association. Serous tumour, the most common histological subtype
of ovarian cancer, showed similar results as total ovarian cancer.
The association between total fat intake and risk of ovarian cancer
was stronger in subgroups of women who were nulliparous or
never used oral contraceptives.
In contrast to findings from a pooled analysis of 12 prospective
cohort studies and recent studies, we found a positive association
between total fat intake and risk of ovarian cancer. The California
Teachers Study, which was not included in the pooled analysis,
found no association with the total fat intake (RRQ5 vs Q1¼0.85,
95% CI: 0.58–1.24, 280 cases) (Chang et al, 2007). Recently, the
Netherlands Cohort study also reported no association of total fat
with risk of ovarian cancer (Gilsing et al, 2011). Most cohort
studies that examined fat intake in relation to ovarian cancer
tended to a narrow range of total fat intake. This limited the ability
to examine more extreme contrasts of total fat intake, thus
associations may not have been detected, if they exist. On the other
hand, the distribution of total fat intake in our study showed a
wide range: the top 10 percentile of our study participants had total
fat intake more than 40% of total energy from fat, whereas the
bottom 10 percentile of participants had less than 20% of total
energy from fat. The wide range of fat intake in our study may be,
in part, due to measurement error inherent to the food frequency
questionnaire. Nevertheless, measurement error in the food
frequency questionnaire used in our study is comparable to that
in the food frequency questionnaire used in other cohort studies
(Subar et al, 2001). In addition, we corrected for measurement
errors in total fat intake and found that the positive association
became stronger, but did not appreciably change. Our finding is
also supported by the Women’s Health Initiative Dietary
Modification Randomized Controlled Trial that investigated the
effect of a low-fat dietary pattern in postmenopausal women
(Prentice et al, 2007). Mean fat intake in the intervention and the
control group at year 1 after randomisation was 24% and 35% of
total energy intake from fat, respectively. After 4–8 years of follow-up,
this trial found that ovarian cancer risk was significantly lower in
the intervention group (hazard ratio¼0.60, 95% CI: 0.38–0.96)
than in the control group.
We observed that fat intake from animal sources, but not from
plant sources, was significantly positively associated with risk of
ovarian cancer. This is consistent with findings from other cohort
studies: a pooled analysis aforementioned reported a suggestive
increase in risk of ovarian cancer for fat intake from animal
sources (RRQ1 vs Q4¼1.15, 95% CI: 0.99–1.33, Ptrend¼0.15) and
the Netherlands Cohort study also observed an increased risk of
ovarian cancer with increased intake of fat from animal foods
(RR¼1.11, 95% CI: 0.99–1.25 for 13g per day increment).
In addition, a case–control study that examined dietary changes
over time observed that substituting non-animal fat for animal
fat between 2 and 7 years before cancer diagnosis or study
recruitment was related to 35% lowered risk of ovarian cancer
(odds ratio¼0.65, 95% CI: 0.50–0.85, for 100kcal increment)
(Lubin et al, 2006). In examining types of fat in relation to ovarian
Table 3 Multivariate relative risks
a and 95% confidence intervals for histological subtypes of ovarian cancer in the NIH-AARP Diet and Health Study,
continuous model
Increment (%)
b All ovarian cancer Serous tumour Endometroid tumour Mucinous tumour
Cases (n) 695 404 66 36
Total fat 10 1.11 (1.01–1.23) 1.14 (1.00–1.30) 0.91 (0.66–1.25) 1.42 (0.93–2.17)
Fat from animal sources 5 1.09 (1.02–1.17) 1.10 (1.01–1.20) 0.99 (0.80–1.24) 1.37 (1.06–1.77)
Fat from plant sources 5 1.02 (0.95–1.10) 1.02 (0.93–1.12) 0.93 (0.73–1.18) 1.02 (0.74–1.39)
Saturated fat 5 1.14 (0.93–1.40) 1.16 (0.89–1.52) 1.28 (0.63–2.62) 1.39 (0.61–3.14)
Monounsaturated fat 5 0.88 (0.67–1.14) 0.96 (0.68–1.36) 0.49 (0.20–1.21) 1.06 (0.36–3.15)
Polyunsaturated fat 5 1.28 (1.02–1.61) 1.13 (0.83–1.53) 1.78 (0.87–3.64) 1.20 (0.46–3.15)
aAdjusted for age, race (white, non-Hispanic, black, non-Hispanic, and others), education (o12 years, high-school graduate, some college, and college graduate/post college),
body mass index (o25, 25–30, 30+ kgm
 2), family history of ovarian cancer (yes, no), duration of oral contraceptive use (0, 1–4, 5–9, 10+ years), parity (0, 1, 2, 3–4, and 5+
children), duration of menopausal hormone therapy use (0, 40-o5, 5–9, 10+ years), and total energy intake (continuous).
bPercent of total energy from fat.
Oral contraceptive use
Never (n=470
b)
Ever (n=219)
P-interaction= 0.14
Parity
Nulliparous (n=132)
1–2 Children (n=263)
3+ Children (n=298)
P-interaction= 0.01
Menopausal hormone therapy use
Never (n=322)
<10 Years (n=227)
10 Years (n=137)
P-interaction= 0.96
Body mass index
<25 (n=310)
25–<30 (n=189)
30 (n=163)
P-interaction= 0.97
1.17 (1.04, 1.32)
0.98 (0.82, 1.17)
1.37 (1.10, 1.71)
1.19 (1.02, 1.40)
0.95 (0.81, 1.10)
1.08 (0.94, 1.25)
1.16 (0.97, 1.38)
1.14 (0.91, 1.42)
1.09 (0.95, 1.26)
1.11 (0.91, 1.34)
1.13 (0.92, 1.40)
RRa (95% CI)
0.5 1.0
RR
1.5 2
Figure 1 Multivariate RRs (adjusted for age, race (white, non-Hispanic,
black, non-Hispanic, others), education (o12 years, high-school graduate,
some college, and college graduate/post college), BMI (o25, 25–30,
30þ kgm
 2), family history of ovarian cancer (yes, no), duration of oral
contraceptive use (0, 1–4, 5–9, 10þ years), parity (0, 1, 2, 3–4, and 5þ
children), duration of MHT use (0, 40t oo5,5–9,10þ years), and total
energy intake (continuous)) and 95% CIs of ovarian cancer for total
fat intake by oral contraceptive use, parity, MHT use, and BMI in the
NIH-AARP Diet and Health Study, continuous model.
aIncrement of
10% of total energy from fat.
bNumber of cases.
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ycancer, both a meta-analysis of case–control studies and the
pooled analysis of cohort studies observed a positive association
with saturated fat intake. However, our study found no association
of saturated fat with risk of ovarian cancer.
Some studies suggested that reproductive and hormonal risk
factors for ovarian cancer differ by histological types (Tung et al,
2003; Soegaard et al, 2007; Gates et al, 2010). However, ours and
two other studies (Risch et al, 1996; Genkinger et al, 2006) that
examined the association between fat intake and ovarian cancer by
histological type did not observe a significant difference in risk
estimates by histological type. Owing to the small number of cases
in mucinous, endometrioid, and clear cell tumours, studies had
limited ability to examine these associations. Further examination
of these relationships in histological subtypes is warranted.
Unlike a pooled analysis that found no effect modification by
reproductive and hormonal factors (Genkinger et al, 2006), we
found that the association between total fat intake and ovarian
cancer risk was modified by parity. A significantly increased risk of
ovarian cancer for total fat intake was observed in women with
no child or 1–2 children, but not in women with 3þ children. In
addition, although the interaction was not statistically significant,
the positive association between total fat and risk of ovarian cancer
was significant in women who never used oral contraceptives, but
not in women ever used oral contraceptives. Given that oral
contraceptive use and parity have been identified as protective
factors for ovarian cancer, women who did not use oral contra-
ceptives or who were nulliparous may be at a higher risk of ovarian
cancer and more susceptible to the detrimental effect of fat on
ovarian cancer risk. On the other hand, among oral contraceptive
users and parous women, the protective effect of oral contraceptive
use and pregnancy may override the harmful effect of high fat
intake. Interestingly, the Netherlands Cohort Study also observed
that the relation of animal fat intake to ovarian cancer risk
was stronger in women who never used oral contraceptive use.
In contrast to our findings, this study observed a significant
association between animal fat intake and risk of ovarian cancer in
parous women, but not in nulliparous women. These findings also
warrant further investigation.
Our study has several limitations. Diet was assessed only once at
baseline, as opposed to repeated assessments during follow-up,
therefore we were not able to examine the changes in fat intake
over time. Similarly, we did not assess fat intake at earlier stages of
life, particularly during reproductive years that may be relevant to
lifelong risk. Measurement error is an inherent limitation in self-
reported dietary assessment. Nevertheless, we were able to correct
measurement error using the calibration study data. Despite a
large number of ovarian cancer cases, we were not able to examine
the association by specific subtypes due to the rarity of some
histological types. The ovarian cancer subtypes were defined using
pathology information provided by state cancer registries and
we were not able to review them. Thus, some misclassification of
subtypes may have occurred.
Our study also has several strengths. This is a large prospective
cohort study in which diet was measure at baseline, thus
decreasing the likelihood of recall bias. In addition, our study
had wide ranges of dietary fat intake providing good statistical
power. We were also able to examine subtypes of ovarian cancer
and adjust for potential ovarian cancer risk factors in addition to
performing stratified analyses by several risk factors.
In conclusion, our findings support the hypothesis that fat
intake, particularly fat from animal sources, increases risk of
ovarian cancer. The association of total fat intake with ovarian
cancer may be modified by hormone and reproductive factors such
as parity and oral contraceptive use. Further investigation is
needed to better understand these associations.
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